- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Octreotide – July 2018
Octreotide: Injection (modified release) 10 mg (as acetate); Vial and diluent syringe injection (mod
Last updated
26 October 2018